Search Results
You are looking at 1 - 4 of 4 items for
- Author: D Gu x
- Refine by access: All content x
Search for other papers by MR Kritzik in
Google Scholar
PubMed
Search for other papers by T Krahl in
Google Scholar
PubMed
Search for other papers by A Good in
Google Scholar
PubMed
Search for other papers by D Gu in
Google Scholar
PubMed
Search for other papers by C Lai in
Google Scholar
PubMed
Search for other papers by H Fox in
Google Scholar
PubMed
Search for other papers by N Sarvetnick in
Google Scholar
PubMed
We have characterized expression of the ErbB receptor family and one of its ligands, heregulin, in an effort to identify molecules associated with pancreatic development and regeneration. In addition to studying expression during fetal pancreatic development, we have also studied expression during pancreatic regeneration in the interferon-gamma (IFNgamma)-transgenic mouse, which exhibits significant duct cell proliferation and new islet formation. These studies demonstrate significant expression of the ErbB2, ErbB3, and ErbB4 receptors, in addition to heregulin isoforms, in the developing murine fetal pancreas. We also report significant ductal expression of these proteins during IFNgamma-mediated pancreatic regeneration. This striking expression was absent in 1-week-old neonates, but was clearly visible in pups by 5 weeks of age. These data therefore indicate that ErbB receptor and ligand expression decline by birth in both the IFNbeta-transgenic and non-transgenic mice, and that expression resumes early in postnatal life in the IFNbeta-transgenic mice. The expression of ErbB receptor family members at sites of islet development and regrowth suggests that these molecules might be relevant to these processes.
Search for other papers by G Liu in
Google Scholar
PubMed
Search for other papers by SV Pakala in
Google Scholar
PubMed
Search for other papers by D Gu in
Google Scholar
PubMed
Search for other papers by T Krahl in
Google Scholar
PubMed
Search for other papers by L Mocnik in
Google Scholar
PubMed
Search for other papers by N Sarvetnick in
Google Scholar
PubMed
In developmental terms, the endocrine system of neither the gut nor the pancreatic islets has been characterized fully. Little is known about the involvement of cholecystokinin (CCK), a gut hormone, involved in regulating the secretion of pancreatic hormones, and pancreatic growth. Here, we tracked CCK-expressing cells in the intestines and pancreata of normal mice (BALB/c), Non Obese Diabetic (NOD) mice and interferon (IFN)-gamma transgenic mice, which exhibit pancreatic regeneration, during embryonic development, the postnatal period and adulthood. We also questioned whether IFN-gamma influences the expression of CCK. The results from embryonic day 16 showed that all three strains had CCK in the acinar region of pancreata, and specifically in alpha cells that also expressed glucagon. However, in adulthood only BALB/c and NOD mice continued this pattern. By contrast, in IFN-gamma transgenic mice, CCK expression was suppressed from birth to 3 months of age in the pancreata but not intestines. However, by 5 months of age, CCK expression appeared in the regenerating pancreatic ductal region of IFN-gamma transgenic mice. In the intestine, CCK expression persisted from fetus to adulthood and was not influenced by IFN-gamma. Intestinal cells expressing CCK did not co-express glucagon, suggesting that these cells are phenotypically distinct from CCK-expressing cells in the pancreatic islets, and the effect of IFN-gamma on CCK varies depending upon the cytokine's specific microenvironment.
Search for other papers by B C Xu in
Google Scholar
PubMed
Search for other papers by W Y Chen in
Google Scholar
PubMed
Search for other papers by T Gu in
Google Scholar
PubMed
Search for other papers by D Ridgway in
Google Scholar
PubMed
Search for other papers by P Wiehl in
Google Scholar
PubMed
Search for other papers by S Okada in
Google Scholar
PubMed
Search for other papers by J J Kopchick in
Google Scholar
PubMed
Abstract
We have previously shown that a bovine (b) GH antagonist, bGH-M8, which possesses three amino acid substitutions in its third α-helix, inhibits mouse 3T3-F442A preadipocyte differentiation. In the current studies, we used the bGH and human (h) GH analogs with single amino acid substitution, bGH-G119R and hGH-G120R, for determining their biological activity using the preadipocyte differentiation assay. Short-term and long-term GH-inducible events were studied during adipose differentiation, including late marker gene expression (adipocyte protein 2), immediate early gene induction (c-fos), and tyrosine phosphorylation of intracellular proteins. The results demonstrated that these GH analogs not only failed to induce these three events, but also antagonized GH induction of c-fos expression and phosphorylation of proteins of apparent molecular mass of 95 kDa. Our present study agrees with the notion that GH must bind to the GH receptor via site one and with a second GH receptor molecule (or with some yet unidentified 'second target') through GH binding site two. This interaction is important for subsequent GH-dependent biological events.
Journal of Endocrinology (1995) 146, 131–139
Search for other papers by ML Krakowski in
Google Scholar
PubMed
Search for other papers by MR Kritzik in
Google Scholar
PubMed
Search for other papers by EM Jones in
Google Scholar
PubMed
Search for other papers by T Krahl in
Google Scholar
PubMed
Search for other papers by J Lee in
Google Scholar
PubMed
Search for other papers by M Arnush in
Google Scholar
PubMed
Search for other papers by D Gu in
Google Scholar
PubMed
Search for other papers by B Mroczkowski in
Google Scholar
PubMed
Search for other papers by N Sarvetnick in
Google Scholar
PubMed
The upregulation of a limited number of growth factors in our interferon-gamma transgenic model for regeneration within the pancreas lead us to propose that these factors are important during pancreatic regeneration. In this study, we have assessed the influence of two growth factors within the pancreas, epidermal growth factor (EGF) and keratinocyte growth factor (KGF), by ectopically expressing these proteins under the control of the human insulin promoter in transgenic mice. This beta-cell-targeted expression of either EGF or KGF resulted in significant morphological changes, including cellular proliferation and disorganized islet growth. Intercrossing the individual Ins-EGF and Ins-KGF transgenic mice resulted in more profound changes in pancreatic morphology including proliferation of pancreatic cells and extensive intra-islet fibrosis. Insulin-producing beta-cells were found in some of the ducts of older Ins-EGF and Ins-EGFxKGF transgenic mice, and amylase-producing cells were observed within the islet structures of the double transgenic mice. These data suggest that both EGF and KGF are capable of affecting pancreatic differentiation and growth, and that co-expression of these molecules in islets has a more substantial impact on the pancreas than does expression of either growth factor alone.
